Literature DB >> 29723107

Lactobacillus gasseri PA-3 utilizes the purines GMP and guanosine and decreases their absorption in rats.

N Yamada1, C Saito1, Y Murayama-Chiba1, H Kano1, Y Asami1, H Itoh1.   

Abstract

Excessive intake of purine-rich foods elevates serum uric acid levels, making it a risk factor for hyperuricemia. We hypothesized that lactic acid bacteria ingested with food might utilize purines and contribute to their decreased absorption in the intestines, thereby preventing hyperuricemia. We previously reported that Lactobacillus gasseri PA-3 (PA-3) incorporates adenosine/inosine and related purines and that oral ingestion of PA-3 reduced the absorption of these purines in rats. However, it is unclear whether PA-3 also decreases the absorption of other purines, such as guanosine 5'-monophosphate (GMP) and guanosine. This study investigated whether PA-3 incorporates GMP and guanosine and reduces their absorption in rats. PA-3 incorporated both purines, with 14C-GMP uptake being greater than that of 14C-guanosine. Radioactivity in rat blood was significantly lower 30, 45, and 60 minutes after administration of 14C-GMP plus PA-3 than after administration of 14C-GMP alone and was significantly lower 15 minutes after administration of 14C-guanosine plus PA-3 than after administration of 14C-guanosine alone. PA-3 incorporates GMP and guanosine in vitro. Oral administration of PA-3 with GMP and guanosine reduces the intestinal absorption of these purines in vivo. These findings, together with those of previous studies, indicate that PA-3 reduces the absorption of major purines contained in foods. PA-3 may also attenuate the excessive absorption of dietary purines in humans, protecting these individuals against hyperuricemia.

Entities:  

Keywords:  PA-3; lactic acid bacteria; uptake of purine

Mesh:

Substances:

Year:  2018        PMID: 29723107     DOI: 10.1080/15257770.2018.1454949

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  4 in total

1.  Engineered Escherichia coli Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment.

Authors:  Rui Zhao; Zimai Li; Yuqing Sun; Wei Ge; Mingyu Wang; Huaiwei Liu; Luying Xun; Yongzhen Xia
Journal:  Gut Microbes       Date:  2022 Jan-Dec

2.  Diagnostic model for predicting hyperuricemia based on alterations of the gut microbiome in individuals with different serum uric acid levels.

Authors:  Meiting Liang; Jingkun Liu; Wujin Chen; Yi He; Mayina Kahaer; Rui Li; Tingting Tian; Yezhou Liu; Bing Bai; Yuena Cui; Shanshan Yang; Wenjuan Xiong; Yan Ma; Bei Zhang; Yuping Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-27       Impact factor: 6.055

Review 3.  Can Probiotics and Diet Promote Beneficial Immune Modulation and Purine Control in Coronavirus Infection?

Authors:  Ana H A Morais; Thais S Passos; Bruna L L Maciel; Juliana K da Silva-Maia
Journal:  Nutrients       Date:  2020-06-10       Impact factor: 5.717

4.  Effect of Lactobacillus gasseri PA3 on gut microbiota in an in vitro colonic simulation.

Authors:  Shasha Xiang; Jian Fu; Kun Ye; Yiqing Zheng; Xuan Zhu; Jie Chen; Yuewen Chen
Journal:  Food Sci Nutr       Date:  2019-11-14       Impact factor: 2.863

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.